Discontinuation of Second Generation (2G) Tyrosine Kinase Inhibitors (TKI) in Chronic Phase (CP)-Chronic Myeloid Leukemia (CML) Patients with Stable Undetectable BCR-ABL Transcripts

被引：35

作者：

Rea, Delphine ^{[1
]}

Rousselot, Philippe ^{[2
]}

Guilhot, Francois ^{[3
]}

Tulliez, Michel ^{[4
]}

Nicolini, Franck E. ^{[5
]}

Guerci-Bresler, Agnes ^{[6
]}

Legros, Laurence ^{[7
]}

Gardembas, Martine ^{[8
]}

Giraudier, Stephane ^{[4
]}

Guillerm, Gaelle ^{[9
]}

Mahon, Francois-Xavier ^{[10
]}

机构：

[1] Hop St Louis, AP HP, Serv Malad Sang, Paris, France

[2] Hop Andre Mignot, Le Chesnay, France

[3] CHU Poitiers, INSERM, CIC 0802, Poitiers, France

[4] Hop Henri Mondor, Dept Hematol, F-94010 Creteil, France

[5] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France

[6] CHU Brabois, Dept Hematol, Vandoeuvre Les Nancy, France

[7] CHU Nice, Hop Archet, Serv Hematol Clin, Nice, France

[8] CHU Angers, Dept Hematol, Angers, France

[9] Hop Augustin Morvan, Brest, France

[10] Univ Victor Segalen, Lab Hematol, Pessac, France

来源：

关键词：

D O I：

10.1182/blood.V120.21.916.916

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

916

引用

页数：2